Selpercatinib capsules have emerged as a breakthrough in targeted therapy for advanced cancers, offering hope to patients with RET-driven tumors, including non-small cell lung and thyroid cancers. Available as Selpercatinib 40 & 80 mg in India, it provides flexible dosing options for patients undergoing treatment.
Recent Comments